comparemela.com

Latest Breaking News On - Better therapeutics inc - Page 7 : comparemela.com

Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023

Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark heinenBetter therapeutics incBetter therapeuticsBetter therapeutic

Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023

08.11.2023 - Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today announced it will release its third quarter 2023 financial results before the market opens on Thursday, .

Better therapeutics incBetter therapeutics

Better Therapeutics : Results of Operations and Financial Condition - Form 8-K -October 30, 2023 at 04:20 pm EDT

Item 2.02 Results of Operations and Financial Condition. On October 27, 2023, Better Therapeutics, Inc. disclosed in its registration statement on Form S-1that.

Better therapeutics incSecurities exchangeBetter therapeuticsCurrent reportSecurities exchange actSecurities actExchange act

Better Therapeutics to participate in the American College of Lifestyle Medicine s 2023 Annual Conference

SAN FRANCISCO - Better Therapeutics, Inc. , a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today announced its participation in the American College of.

United statesMark heinenElizabeth pashMark bermanEmma williamsExchange commissionDrug administrationHead of medical affairsBetter therapeutics incAmerican college of lifestyle medicineLifestyle medicineMedicine annual conferenceChief medical officerMedical affairsChief medical officeRisk factor

Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes

AspyreRx is the first FDA-authorized digital behavioral therapeutic device delivering cognitive behavioral therapy for the treatment of a cardiometabolic disease As previously reported, adding.

United statesDiane gomez thinnesFrank karbeDavid kerrExchange commissionDrug administrationDigital healthDiabetes technology societyHealth economicsGoogle play storesOutcomes researchBetter therapeutics incBetter therapeuticsApple appGoogle playChief commercial officer

vimarsana © 2020. All Rights Reserved.